原发性肝癌放射治疗.pptx

RT for hepatocelluar carcinoma;Epidemiology (worldwide);Epidemiology (worldwide);Epidemiology (China);Topics;Topics;Liver function tests;Liver function tests;Liver function tests (clinical grading systems);Liver function tests;Topics;TNM stage;Staging systems;CLIP scoring system;BCLC staging classification;Topics;BCLC treatment options;Evidence-based guidelines in Japan;BCLC treatment outcomes;BCLC treatment options;Topics;Radiotherapy;Radiotherapy;Palliative therapy;Palliative therapy (summary);Radiotherapy;Conformal RT;Conformal RT;Conformal RT;Conformal RT (summary);SBRT;SBRT;SBRT (summary);Charged particle therapy;Charged particle therapy;Charged particle therapy;Charged particle therapy (summary);Trans-arterial Radio-embolisation (TARE);TARE;TARE;TARE (summary);Brachytherapy;Brachytherapy;Brachytherapy;Radiotherapy;Tumor thrombosis therapy;Tumor thrombosis therapy;Tumor thrombosis therapy;Tumor thrombosis therapy;Tumor thrombosis therapy;Tumor thrombosis therapy;Tumor thrombosis therapy;Tumor thrombosis therapy (summary);Radiotherapy;Combined modality treatment;Combined modality treatment;Chemotherapy and RT;TACE and RT;TACE and RT;TACE and RT;TACE and RT;TACE and RT;TACE and RT;TACE and RT;TACE and RT;TACE and RT;TACE and RT;TACE and RT;TACE and RT;TACE and RT (summary);Molecular-targeted agents and RT;Molecular-targeted agents and RT;Molecular-targeted agents and RT;Molecular-targeted agents and RT;Molecular-targeted agents and RT;Molecular-targeted agents and RT;Molecular-targeted agents and RT;Combined modality treatment (summary);Radiotherapy;Bridge to liver transplant;Bridge to liver transplant;Radiotherapy;Imaging in HCC;Imaging in HCC;Imaging in HCC;Imaging in HCC;Imaging in HCC;Imaging in HCC;Imaging in HCC;Imaging in HCC;Imaging in HCC;Imaging in HCC;Imaging in HCC;Imaging in HCC (summary);Radiotherapy;RT response assessment;RT response assessment;RT summary (1);RT summary (2);Topics;Toxicities;RILD;RILD;RILD;RILD (veno-occlusive disease, VOD);RILD (V